GIVLAARI 189 mg/mL, solution injectable

Business Listing - September 04, 2021

GIVLAARI 189 mg/mL, solution injectable

GIVLAARI 189 mg/mL, solution injectable solution injectable sous-cutanée Autorisation active Procédure centralisée Commercialisée 3/2/2020 ALNYLAM NETHERLANDS (PAYS-BAS)

Tags & Categories

active solution injectable autorisation procédure commercialisée cutanée centralisée givlaari alnylam

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business